Raymond James & Associates’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,700
| Closed | -$13.8K | – | 3757 |
|
|
2023
Q2 | $13.8K | Sell |
1,700
-50
| -3% | -$405 | ﹤0.01% | 3736 |
|
|
2023
Q1 | $12.2K | Hold |
1,750
| – | – | ﹤0.01% | 3778 |
|
|
2022
Q4 | $12.4K | Hold |
1,750
| – | – | ﹤0.01% | 3748 |
|
|
2022
Q3 | $27K | Buy |
+1,750
| New | +$27K | ﹤0.01% | 3709 |
|
|
2018
Q3 | – | Sell |
-1,056
| Closed | -$235K | – | 3500 |
|
|
2018
Q2 | $235K | Sell |
1,056
-2,808
| -73% | -$625K | ﹤0.01% | 3148 |
|
|
2018
Q1 | $883K | Buy |
3,864
+35
| +0.9% | +$8K | ﹤0.01% | 2217 |
|
|
2017
Q4 | $1M | Buy |
3,829
+1,625
| +74% | +$426K | ﹤0.01% | 2124 |
|
|
2017
Q3 | $495K | Buy |
2,204
+478
| +28% | +$107K | ﹤0.01% | 2487 |
|
|
2017
Q2 | $472K | Buy |
1,726
+198
| +13% | +$54.1K | ﹤0.01% | 2445 |
|
|
2017
Q1 | $370K | Buy |
1,528
+334
| +28% | +$80.9K | ﹤0.01% | 2553 |
|
|
2016
Q4 | $248K | Buy |
+1,194
| New | +$248K | ﹤0.01% | 2739 |
|